(Q41449183)

30 September 2017

1 reference

title

Hormonal therapy in the management of prostate cancer: from Huggins to the present (English)

1 reference

30 September 2017

Garnick MB

1

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

49

1 reference

30 September 2017

issue

3A Suppl

1 reference

30 September 2017

page(s)

5-15

1 reference

STUDIES ON PROSTATIC CANCER

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Prostate cancer: screening, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Prostate cancer: emerging concepts. Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urolo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Estrogens in the Treatment of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Anti-androgens in treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900163-5

7 January 2021

10.1016/S0090-4295(97)00163-5

Identifiers

DOI

1 reference

30 September 2017

1 reference